{"transactions":[{"id":2261943,"issuer":{"id":7024,"kind":"organization","name":"DarioHealth Corp.","symbol":"DRIO"},"owners":[{"id":127085,"kind":"person","name":"Bacher Dror","position":1,"cik":"0001710439","reported_name":"Bacher Dror","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2022-05-20T17:01:50.000Z","date":"2022-05-18","kind":"grant","acquired":true,"shares":95000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares vest over three years as follows: 8.333% shall vest after 3 months from the grant date, and the remaining shares vest in 11 equal instalments every 3 months thereafter."}],"balance_after":265926,"source":{"system":"sec-edgar","filing":"0001104659-22-063449","document":"tm2216123-4_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1710439/000110465922063449/tm2216123-4_4seq1.xml","form_type":"4"}},{"id":2517851,"issuer":{"id":7024,"kind":"organization","name":"DarioHealth Corp.","symbol":"DRIO"},"owners":[{"id":127085,"kind":"person","name":"Bacher Dror","position":1,"cik":"0001710439","reported_name":"Bacher Dror","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2021-11-10T20:00:53.000Z","date":"2021-11-08","kind":"sale","acquired":false,"shares":804,"price":19.091,"value":15349.164,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 1, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $19.03 to $19.19, inclusive. The Reporting Person undertakes to provide to DarioHealth Corp. (the \"Company\"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2)."}],"balance_after":170926,"source":{"system":"sec-edgar","filing":"0001104659-21-137138","document":"tm2132548-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1710439/000110465921137138/tm2132548-1_4seq1.xml","form_type":"4"}},{"id":2521487,"issuer":{"id":7024,"kind":"organization","name":"DarioHealth Corp.","symbol":"DRIO"},"owners":[{"id":127085,"kind":"person","name":"Bacher Dror","position":1,"cik":"0001710439","reported_name":"Bacher Dror","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2021-11-08T18:00:37.000Z","date":"2021-11-05","kind":"sale","acquired":false,"shares":200,"price":19.06,"value":3812.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 1, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $19.03 to $19.09, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (3)."}],"balance_after":171730,"source":{"system":"sec-edgar","filing":"0001104659-21-135790","document":"tm2132279-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1710439/000110465921135790/tm2132279-1_4seq1.xml","form_type":"4"}},{"id":2521486,"issuer":{"id":7024,"kind":"organization","name":"DarioHealth Corp.","symbol":"DRIO"},"owners":[{"id":127085,"kind":"person","name":"Bacher Dror","position":1,"cik":"0001710439","reported_name":"Bacher Dror","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2021-11-08T18:00:37.000Z","date":"2021-11-04","kind":"sale","acquired":false,"shares":200,"price":19.08,"value":3816.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 1, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $19.06 to $19.10, inclusive. The Reporting Person undertakes to provide to DarioHealth Corp. (the \"Company\"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2)."}],"balance_after":171930,"source":{"system":"sec-edgar","filing":"0001104659-21-135790","document":"tm2132279-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1710439/000110465921135790/tm2132279-1_4seq1.xml","form_type":"4"}},{"id":2524586,"issuer":{"id":7024,"kind":"organization","name":"DarioHealth Corp.","symbol":"DRIO"},"owners":[{"id":127085,"kind":"person","name":"Bacher Dror","position":1,"cik":"0001710439","reported_name":"Bacher Dror","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2021-11-04T18:00:50.000Z","date":"2021-11-03","kind":"sale","acquired":false,"shares":8016,"price":19.129,"value":153338.064,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 1, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $19.00 to $19.38, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (3)."}],"balance_after":172130,"source":{"system":"sec-edgar","filing":"0001104659-21-134531","document":"tm2131978-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1710439/000110465921134531/tm2131978-1_4seq1.xml","form_type":"4"}},{"id":2524585,"issuer":{"id":7024,"kind":"organization","name":"DarioHealth Corp.","symbol":"DRIO"},"owners":[{"id":127085,"kind":"person","name":"Bacher Dror","position":1,"cik":"0001710439","reported_name":"Bacher Dror","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2021-11-04T18:00:50.000Z","date":"2021-11-02","kind":"sale","acquired":false,"shares":4363,"price":19.065,"value":83180.595,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 1, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $19.00 to $19.15, inclusive. The Reporting Person undertakes to provide to DarioHealth Corp. (the \"Company\"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2)."}],"balance_after":180146,"source":{"system":"sec-edgar","filing":"0001104659-21-134531","document":"tm2131978-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1710439/000110465921134531/tm2131978-1_4seq1.xml","form_type":"4"}},{"id":2544530,"issuer":{"id":7024,"kind":"organization","name":"DarioHealth Corp.","symbol":"DRIO"},"owners":[{"id":127085,"kind":"person","name":"Bacher Dror","position":1,"cik":"0001710439","reported_name":"Bacher Dror","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2021-10-12T16:45:46.000Z","date":"2021-10-10","kind":"grant","acquired":true,"shares":357,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reporting person was awarded such securities in exchange for waiving compensation owed for the fourth quarter of 2021."}],"balance_after":184509,"source":{"system":"sec-edgar","filing":"0001104659-21-125371","document":"tm2129692d1_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1710439/000110465921125371/tm2129692d1_4.xml","form_type":"4"}},{"id":2629243,"issuer":{"id":7024,"kind":"organization","name":"DarioHealth Corp.","symbol":"DRIO"},"owners":[{"id":127085,"kind":"person","name":"Bacher Dror","position":1,"cik":"0001710439","reported_name":"Bacher Dror","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2021-07-20T16:30:37.000Z","date":"2021-07-18","kind":"grant","acquired":true,"shares":353,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reporting person was awarded such securities in exchange for waiving compensation owed for the third quarter of 2021."}],"balance_after":184152,"source":{"system":"sec-edgar","filing":"0001104659-21-093981","document":"tm2122591-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1710439/000110465921093981/tm2122591-1_4seq1.xml","form_type":"4"}},{"id":2639444,"issuer":{"id":7024,"kind":"organization","name":"DarioHealth Corp.","symbol":"DRIO"},"owners":[{"id":127085,"kind":"person","name":"Bacher Dror","position":1,"cik":"0001710439","reported_name":"Bacher Dror","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2021-07-07T17:30:52.000Z","date":"2021-07-06","kind":"sale","acquired":false,"shares":2479,"price":20.32,"value":50373.28,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 1, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.03 to $20.86, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (3)."}],"balance_after":183799,"source":{"system":"sec-edgar","filing":"0001104659-21-089871","document":"tm2121465-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1710439/000110465921089871/tm2121465-1_4seq1.xml","form_type":"4"}},{"id":2639443,"issuer":{"id":7024,"kind":"organization","name":"DarioHealth Corp.","symbol":"DRIO"},"owners":[{"id":127085,"kind":"person","name":"Bacher Dror","position":1,"cik":"0001710439","reported_name":"Bacher Dror","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2021-07-07T17:30:52.000Z","date":"2021-07-02","kind":"sale","acquired":false,"shares":11021,"price":20.63,"value":227363.23,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 1, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.18 to $21.11, inclusive. The Reporting Person undertakes to provide to DarioHealth Corp. (the \"Company\"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2)."}],"balance_after":186278,"source":{"system":"sec-edgar","filing":"0001104659-21-089871","document":"tm2121465-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1710439/000110465921089871/tm2121465-1_4seq1.xml","form_type":"4"}},{"id":2727403,"issuer":{"id":7024,"kind":"organization","name":"DarioHealth Corp.","symbol":"DRIO"},"owners":[{"id":127085,"kind":"person","name":"Bacher Dror","position":1,"cik":"0001710439","reported_name":"Bacher Dror","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2021-05-05T16:06:03.000Z","date":"2021-05-03","kind":"grant","acquired":true,"shares":346,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reporting person was awarded such securities in exchange for waiving compensation owed for the second quarter of 2021."}],"balance_after":197299,"source":{"system":"sec-edgar","filing":"0001104659-21-061705","document":"tm2115112d1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1710439/000110465921061705/tm2115112d1_4seq1.xml","form_type":"4"}},{"id":2900834,"issuer":{"id":7024,"kind":"organization","name":"DarioHealth Corp.","symbol":"DRIO"},"owners":[{"id":127085,"kind":"person","name":"Bacher Dror","position":1,"cik":"0001710439","reported_name":"Bacher Dror","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Restricted Stock Grant","published_at":"2021-01-21T16:06:23.000Z","date":"2021-01-19","kind":"grant","acquired":true,"shares":100580,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F2","text":"The shares vest over three years as follows: 8.333% shall vest on March 31, 2021, and the remaining shares vest in 11 equal instalments every 3 months thereafter."}],"balance_after":196953,"source":{"system":"sec-edgar","filing":"0001104659-21-006284","document":"tm213677-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1710439/000110465921006284/tm213677-1_4seq1.xml","form_type":"4"}},{"id":2900833,"issuer":{"id":7024,"kind":"organization","name":"DarioHealth Corp.","symbol":"DRIO"},"owners":[{"id":127085,"kind":"person","name":"Bacher Dror","position":1,"cik":"0001710439","reported_name":"Bacher Dror","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2021-01-21T16:06:23.000Z","date":"2021-01-19","kind":"grant","acquired":true,"shares":1039,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reporting person was awarded such securities in exchange for waiving compensation owed for the first quarter of 2021."}],"balance_after":96373,"source":{"system":"sec-edgar","filing":"0001104659-21-006284","document":"tm213677-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1710439/000110465921006284/tm213677-1_4seq1.xml","form_type":"4"}},{"id":3002952,"issuer":{"id":7024,"kind":"organization","name":"DarioHealth Corp.","symbol":"DRIO"},"owners":[{"id":127085,"kind":"person","name":"Bacher Dror","position":1,"cik":"0001710439","reported_name":"Bacher Dror","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2020-10-20T16:08:27.000Z","date":"2020-10-16","kind":"grant","acquired":true,"shares":4746,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reporting person was awarded such securities in exchange for waiving compensation owed for the fourth quarter of 2020, and for additional compensation waived between April 2020 and July 2020."}],"balance_after":95334,"source":{"system":"sec-edgar","filing":"0001104659-20-116430","document":"tm2033754d3_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1710439/000110465920116430/tm2033754d3_4.xml","form_type":"4"}},{"id":3034459,"issuer":{"id":7024,"kind":"organization","name":"DarioHealth Corp.","symbol":"DRIO"},"owners":[{"id":127085,"kind":"person","name":"Bacher Dror","position":1,"cik":"0001710439","reported_name":"Bacher Dror","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2020-09-10T16:05:41.000Z","date":"2020-09-08","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reporting person was awarded such securities under the Issuer's Amended and Restated 2012 Equity Incentive Plan."}],"balance_after":90588,"source":{"system":"sec-edgar","filing":"0001104659-20-103939","document":"tm2030511-1_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1710439/000110465920103939/tm2030511-1_4.xml","form_type":"4"}},{"id":3077883,"issuer":{"id":7024,"kind":"organization","name":"DarioHealth Corp.","symbol":"DRIO"},"owners":[{"id":127085,"kind":"person","name":"Bacher Dror","position":1,"cik":"0001710439","reported_name":"Bacher Dror","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2020-07-22T16:10:52.000Z","date":"2020-07-20","kind":"grant","acquired":true,"shares":1676,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reporting person was awarded such securities in exchange for waiving compensation owed for the third quarter of 2020."}],"balance_after":80588,"source":{"system":"sec-edgar","filing":"0001104659-20-085627","document":"tm2025176d6_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1710439/000110465920085627/tm2025176d6_4.xml","form_type":"4"}},{"id":3180763,"issuer":{"id":7024,"kind":"organization","name":"DarioHealth Corp.","symbol":"DRIO"},"owners":[{"id":127085,"kind":"person","name":"Bacher Dror","position":1,"cik":"0001710439","reported_name":"Bacher Dror","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2020-04-07T16:08:36.000Z","date":"2020-04-03","kind":"grant","acquired":true,"shares":1628,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reporting person was awarded such securities in exchange for waiving compensation owed for the second quarter of 2020."}],"balance_after":78912,"source":{"system":"sec-edgar","filing":"0001104659-20-044161","document":"tm2015091d10_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1710439/000110465920044161/tm2015091d10_4.xml","form_type":"4"}},{"id":3270810,"issuer":{"id":7024,"kind":"organization","name":"DarioHealth Corp.","symbol":"DRIO"},"owners":[{"id":127085,"kind":"person","name":"Bacher Dror","position":1,"cik":"0001710439","reported_name":"Bacher Dror","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (right to buy)","published_at":"2020-02-14T16:15:17.000Z","date":"2020-02-12","kind":"grant","acquired":true,"shares":28664,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options will vest in twelve equal quarterly installments over a three year period commencing on February 10, 2020, subject to the Director's continued employment by the company. The option will not be subject to section 6(i) (Termination for Continuous Services) of the Plan and will be exercisable until its expiration date on the sixth anniversary from its grant date"}],"balance_after":28664,"derivative":{"exercise_price":7.736,"expiration_date":"2026-02-12","underlying":"Common Stock","underlying_shares":28664},"source":{"system":"sec-edgar","filing":"0001104659-20-021775","document":"tm207834-9_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1710439/000110465920021775/tm207834-9_4.xml","form_type":"4"}},{"id":3270809,"issuer":{"id":7024,"kind":"organization","name":"DarioHealth Corp.","symbol":"DRIO"},"owners":[{"id":127085,"kind":"person","name":"Bacher Dror","position":1,"cik":"0001710439","reported_name":"Bacher Dror","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2020-02-14T16:15:17.000Z","date":"2020-02-12","kind":"grant","acquired":true,"shares":45000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":77284,"source":{"system":"sec-edgar","filing":"0001104659-20-021775","document":"tm207834-9_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1710439/000110465920021775/tm207834-9_4.xml","form_type":"4"}},{"id":3297764,"issuer":{"id":7024,"kind":"organization","name":"DarioHealth Corp.","symbol":"DRIO"},"owners":[{"id":127085,"kind":"person","name":"Bacher Dror","position":1,"cik":"0001710439","reported_name":"Bacher Dror","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2020-01-30T16:07:54.000Z","date":"2020-01-28","kind":"grant","acquired":true,"shares":1677,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reporting person was awarded such securities in exchange for waiving compensation owed for the first quarter of 2020."}],"balance_after":32284,"source":{"system":"sec-edgar","filing":"0001104659-20-008691","document":"tm206156d10_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1710439/000110465920008691/tm206156d10_4.xml","form_type":"4"}},{"id":3331346,"issuer":{"id":7024,"kind":"organization","name":"DarioHealth Corp.","symbol":"DRIO"},"owners":[{"id":127085,"kind":"person","name":"Bacher Dror","position":1,"cik":"0001710439","reported_name":"Bacher Dror","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2019-12-26T16:09:47.000Z","date":"2019-12-23","kind":"grant","acquired":true,"shares":2633,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reporting person was awarded such securities in exchange for waiving compensation owed for the fourth quarter of 2019 in the aggregate amount of $11,352.36."}],"balance_after":30607,"source":{"system":"sec-edgar","filing":"0001104659-19-076126","document":"tm1927375-10_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1710439/000110465919076126/tm1927375-10_4.xml","form_type":"4"}},{"id":3464209,"issuer":{"id":7024,"kind":"organization","name":"DarioHealth Corp.","symbol":"DRIO"},"owners":[{"id":127085,"kind":"person","name":"Bacher Dror","position":1,"cik":"0001710439","reported_name":"Bacher Dror","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2019-07-10T16:05:45.000Z","date":"2019-07-09","kind":"grant","acquired":true,"shares":63690,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reporting person was awarded such securities in exchange for waiving compensation owed for the second and third quarters of 2019 in the aggregate amount of $38,215.04."}],"balance_after":559430,"source":{"system":"sec-edgar","filing":"0001144204-19-034294","document":"tv524957_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1710439/000114420419034294/tv524957_4.xml","form_type":"4"}},{"id":3545637,"issuer":{"id":7024,"kind":"organization","name":"DarioHealth Corp.","symbol":"DRIO"},"owners":[{"id":127085,"kind":"person","name":"Bacher Dror","position":1,"cik":"0001710439","reported_name":"Bacher Dror","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2019-04-30T17:01:07.000Z","date":"2019-04-29","kind":"grant","acquired":true,"shares":93769,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Of the amount shown, 11,721 shares were awarded in lieu of a cash bonus compensation for the fiscal year of 2018 in the amount of $11,721.56."}],"balance_after":495740,"source":{"system":"sec-edgar","filing":"0001144204-19-022459","document":"tv520229_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1710439/000114420419022459/tv520229_4.xml","form_type":"4"}},{"id":3683923,"issuer":{"id":7024,"kind":"organization","name":"DarioHealth Corp.","symbol":"DRIO"},"owners":[{"id":127085,"kind":"person","name":"Bacher Dror","position":1,"cik":"0001710439","reported_name":"Bacher Dror","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2019-01-29T16:03:36.000Z","date":"2019-01-27","kind":"grant","acquired":true,"shares":18361,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reporting person was awarded such securities in exchange for waiving compensation owed for the first quarter of 2019 in the amount of $18,361.85."}],"balance_after":401971,"source":{"system":"sec-edgar","filing":"0001144204-19-003517","document":"tv511871_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1710439/000114420419003517/tv511871_4.xml","form_type":"4"}},{"id":3796100,"issuer":{"id":7024,"kind":"organization","name":"DarioHealth Corp.","symbol":"DRIO"},"owners":[{"id":127085,"kind":"person","name":"Bacher Dror","position":1,"cik":"0001710439","reported_name":"Bacher Dror","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2018-10-05T16:21:35.000Z","date":"2018-10-03","kind":"grant","acquired":true,"shares":19080,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reporting person was awarded such securities in exchange for waiving compensation owed for the fourth quarter of 2018 in the amount of $18,964.29"}],"balance_after":383610,"source":{"system":"sec-edgar","filing":"0001144204-18-052741","document":"tv504209_form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1710439/000114420418052741/tv504209_form4.xml","form_type":"4"}},{"id":3870414,"issuer":{"id":7024,"kind":"organization","name":"DarioHealth Corp.","symbol":"DRIO"},"owners":[{"id":127085,"kind":"person","name":"Bacher Dror","position":1,"cik":"0001710439","reported_name":"Bacher Dror","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2018-07-10T16:05:56.000Z","date":"2018-07-09","kind":"grant","acquired":true,"shares":13464,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reporting person was awarded such securities in exchange for waiving compensation owed for the second quarter of 2018 in the amount of $688.52, and for the third quarter of 2018 in the amount of $18,917.35."}],"balance_after":364530,"source":{"system":"sec-edgar","filing":"0001144204-18-037837","document":"tv498255_form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1710439/000114420418037837/tv498255_form4.xml","form_type":"4"}},{"id":3900149,"issuer":{"id":7024,"kind":"organization","name":"DarioHealth Corp.","symbol":"DRIO"},"owners":[{"id":127085,"kind":"person","name":"Bacher Dror","position":1,"cik":"0001710439","reported_name":"Bacher Dror","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2018-06-08T16:06:18.000Z","date":"2018-06-06","kind":"grant","acquired":true,"shares":166015,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Of the amount shown, 6,183 shares were awarded in lieu of a cash bonus compensation for the fiscal year of 2017 in the amount of $10,690.63."}],"balance_after":351066,"source":{"system":"sec-edgar","filing":"0001144204-18-033541","document":"tv496160_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1710439/000114420418033541/tv496160_4.xml","form_type":"4"}},{"id":3957267,"issuer":{"id":7024,"kind":"organization","name":"DarioHealth Corp.","symbol":"DRIO"},"owners":[{"id":127085,"kind":"person","name":"Bacher Dror","position":1,"cik":"0001710439","reported_name":"Bacher Dror","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2018-04-25T16:06:38.000Z","date":"2018-04-23","kind":"grant","acquired":true,"shares":43801,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reporting person was awarded 11,349 shares in exchange for waiving compensation owed for the second quarter of 2018 in the amount of $17,486.30, and 32,452 shares in lieu of receiving a one-time cash bonus compensation in the amount of $50,000."}],"balance_after":185051,"source":{"system":"sec-edgar","filing":"0001144204-18-022372","document":"tv491861_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1710439/000114420418022372/tv491861_4.xml","form_type":"4"}},{"id":4104352,"issuer":{"id":7024,"kind":"organization","name":"DarioHealth Corp.","symbol":"DRIO"},"owners":[{"id":127085,"kind":"person","name":"Bacher Dror","position":1,"cik":"0001710439","reported_name":"Bacher Dror","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2018-01-08T16:15:19.000Z","date":"2018-01-04","kind":"grant","acquired":true,"shares":11306,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reporting person was awarded 9,390 shares in exchange for waiving compensation owed for the first quarter of 2018 in the amount of $17,743.52."}],"balance_after":141250,"source":{"system":"sec-edgar","filing":"0001144204-18-001303","document":"tv482694_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1710439/000114420418001303/tv482694_4.xml","form_type":"4"}},{"id":4180701,"issuer":{"id":7024,"kind":"organization","name":"DarioHealth Corp.","symbol":"DRIO"},"owners":[{"id":127085,"kind":"person","name":"Bacher Dror","position":1,"cik":"0001710439","reported_name":"Bacher Dror","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2017-10-25T16:09:19.000Z","date":"2017-10-23","kind":"grant","acquired":true,"shares":17470,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reporting person was awarded 9,390 shares in exchange for waiving compensation owed for the fourth quarter of 2017 in the amount of $17,431.79 and 8,080 shares in lieu of receiving a cash bonus compensation in the amount of $15,000."}],"balance_after":129944,"source":{"system":"sec-edgar","filing":"0001144204-17-054101","document":"tv477614_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1710439/000114420417054101/tv477614_4.xml","form_type":"4"}},{"id":4251192,"issuer":{"id":7024,"kind":"organization","name":"DarioHealth Corp.","symbol":"DRIO"},"owners":[{"id":127085,"kind":"person","name":"Bacher Dror","position":1,"cik":"0001710439","reported_name":"Bacher Dror","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2017-07-26T16:07:04.000Z","date":"2017-07-25","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reporting person was awarded such securities in conjunction with his appointment as Chief Operating Officer of the registrant."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Employee stock options to purchase shares of Common Stock of the registrant which shall vest over a three year period in twelve equal quarterly installments commencing on the date of grant, subject to the Reporting Person's continued employment by the registrant."}],"balance_after":10000,"derivative":{"exercise_price":2.46,"expiration_date":"2027-07-25","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001144204-17-038326","document":"v471443_form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1710439/000114420417038326/v471443_form4.xml","form_type":"4"}},{"id":4251191,"issuer":{"id":7024,"kind":"organization","name":"DarioHealth Corp.","symbol":"DRIO"},"owners":[{"id":127085,"kind":"person","name":"Bacher Dror","position":1,"cik":"0001710439","reported_name":"Bacher Dror","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2017-07-26T16:07:04.000Z","date":"2017-07-25","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reporting person was awarded such securities in conjunction with his appointment as Chief Operating Officer of the registrant."}],"balance_after":112474,"source":{"system":"sec-edgar","filing":"0001144204-17-038326","document":"v471443_form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1710439/000114420417038326/v471443_form4.xml","form_type":"4"}}]}